NCT00239356 - Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials | Biotech Hunter

Enrollment

119

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

Schizophrenia

Interventions

DRUG

Aripiprazole

Tablets, Oral, 10 - 30 mg, once daily, greater than 52 weeks depending upon Aripiprazole approval in respective country

Trial Locations (20)

Local Institution, Ottawa

Local Institution, Sherbrooke

Local Institution, Rijeka

Local Institution, Zagreb

Local Institution, Hradec Králové

Local Institution, Prague

Local Institution, Nantes Orvault

Local Institution, Rennes

Local Institution, Uzès

Local Institution, Budapest

Local Institution, Győr

Local Institution, Vught

Local Institution, Krakow

Local Institution, Poznan

Local Institution, Bucharest

Local Institution, Saint Petersburg

Local Institution, Westdene

Local Institution, Johannesburg

Local Institution, Cape Town

Local Institution, Antrim